tiprankstipranks
Cyclo Therapeutics (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Technical Analysis

189 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Cyclo Therapeutics’s (CYTH) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Cyclo Therapeutics is a Sell.
Cyclo Therapeutics’s (CYTH) 20-Day exponential moving average is 1.42, while Cyclo Therapeutics’s (CYTH) share price is $1.43, making it a Sell.
Cyclo Therapeutics’s (CYTH) 50-Day exponential moving average is 1.44, while Cyclo Therapeutics’s (CYTH) share price is $1.43, making it a Sell.

Cyclo Therapeutics (CYTH) Pivot Points

May 16, 2024, 09:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.28
1.34
1.37
1.43
1.46
1.52
1.55
Fibonacci
1.34
1.37
1.40
1.43
1.46
1.48
1.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cyclo Therapeutics (CYTH) Moving Averages

May 16, 2024, 09:35 AM
Period
Simple
Exponential
MA5
1.45Sell
1.44Sell
MA10
1.47Sell
1.44Sell
MA20
1.38Buy
1.42Sell
MA50
1.43Sell
1.44Sell
MA100
1.56Sell
1.48Sell
MA200
1.46Sell
1.47Sell
Cyclo Therapeutics’s (CYTH) 10-Day exponential moving average is 1.44, while Cyclo Therapeutics’s (CYTH) share price is $1.43, making it a Sell.
Cyclo Therapeutics’s (CYTH) 100-Day exponential moving average is 1.48, while Cyclo Therapeutics’s (CYTH) share price is $1.43, making it a Sell.
Cyclo Therapeutics’s (CYTH) stock price is $1.43 and Cyclo Therapeutics’s (CYTH) 50-day simple moving average is 1.43, creating a Sell signal.
Cyclo Therapeutics’s (CYTH) stock price is $1.43 and Cyclo Therapeutics’s (CYTH) 100-day simple moving average is 1.56, creating a Sell signal.
Cyclo Therapeutics’s (CYTH) stock price is $1.43 and Cyclo Therapeutics’s (CYTH) 200-day simple moving average is 1.46, creating a Sell signal.

Cyclo Therapeutics (CYTH) Technical Indicators

May 16, 2024, 09:35 AM
Name
Value
Implied Action
RSI (14)
49.50
Neutral
STOCH (9,6)
16.32
Buy
STOCHRSI (14)
50.44
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
21.09
Neutral
Williams %R
-58.22
Buy
CCI (14)
37.21
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
22.73
Sell
ROC
8.46
Buy
Cyclo Therapeutics’s (CYTH) Relative Strength Index (RSI) is 49.50, creating a Neutral signal.
Cyclo Therapeutics’s (CYTH) Trend Strength Indicator (ADX) is 21.09, creating a Neutral signal.
Cyclo Therapeutics’s (CYTH) Commodity Channel Index (CCI) is 37.21, creating a Neutral signal.
Cyclo Therapeutics’s (CYTH) Price Rate of Change (ROC) is 8.46, creating a Buy signal.

FAQ

Is CYTH a Buy, Hold, or Sell?
Based on CYTH’s technical indicators, CYTH is a Sell.
    What is CYTH’s RSI (14)?
    CYTH’s RSI (14) is 49.50, which suggests CYTH is a Neutral.
      What is CYTH’s MACD?
      CYTH’s MACD is 0.02, which suggests CYTH is a Sell.
        What is CYTH’s 5-day moving average?
        CYTH’s 5-day moving average is 1.45, which suggests CYTH is a Sell.
          What is CYTH’s 20-day moving average?
          CYTH 20-day moving average is 1.38, which suggests CYTH is a Buy.
            What is CYTH’s 50-day moving average?
            CYTH’s 50-day moving average is 1.43, which suggests CYTH is a Sell.
              What is CYTH’s 200-day moving average?
              CYTH’s 200-day moving average is 1.46, which suggests CYTH is a Sell.
                What is CYTH’s Williams % R (14)?
                CYTH’s Williams % R (14) is -58.22, which suggests CYTH is a Buy.
                  What is CYTH’s CCI (14)?
                  CYTH’s CCI (14) is 37.21, which suggests CYTH is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis